191 related articles for article (PubMed ID: 35891482)
21. Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates.
Pratt WD; Gibbs P; Pitt ML; Schmaljohn AL
Vaccine; 1998; 16(9-10):1056-64. PubMed ID: 9682359
[TBL] [Abstract][Full Text] [Related]
22. Entry Sites of Venezuelan and Western Equine Encephalitis Viruses in the Mouse Central Nervous System following Peripheral Infection.
Phillips AT; Rico AB; Stauft CB; Hammond SL; Aboellail TA; Tjalkens RB; Olson KE
J Virol; 2016 Jun; 90(12):5785-96. PubMed ID: 27053560
[TBL] [Abstract][Full Text] [Related]
23. Neutralising antibodies for Mayaro virus in Pantanal, Brazil.
Pauvolid-Corrêa A; Juliano RS; Campos Z; Velez J; Nogueira RM; Komar N
Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):125-33. PubMed ID: 25742272
[TBL] [Abstract][Full Text] [Related]
24. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
[TBL] [Abstract][Full Text] [Related]
25. Vaccine Advances against Venezuelan, Eastern, and Western Equine Encephalitis Viruses.
Stromberg ZR; Fischer W; Bradfute SB; Kubicek-Sutherland JZ; Hraber P
Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32503232
[TBL] [Abstract][Full Text] [Related]
26. Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses.
Hu WG; Steigerwald R; Kalla M; Volkmann A; Noll D; Nagata LP
Vaccine; 2018 Aug; 36(34):5194-5203. PubMed ID: 30037666
[TBL] [Abstract][Full Text] [Related]
27. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
[TBL] [Abstract][Full Text] [Related]
28. 1,5-Iodonaphthyl azide-inactivated V3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus.
Gupta P; Sharma A; Spurgers KB; Bakken RR; Eccleston LT; Cohen JW; Honnold SP; Glass PJ; Maheshwari RK
Vaccine; 2016 May; 34(25):2762-5. PubMed ID: 27129427
[TBL] [Abstract][Full Text] [Related]
29. Cross-Strain Neutralizing and Protective Monoclonal Antibodies against EEEV or WEEV.
Phelps AL; O'Brien LM; Ulaeto DO; Holtsberg FW; Liao GC; Douglas R; Aman MJ; Glass PJ; Moyer CL; Ennis J; Zeitlin L; Nagata LP; Hu WG
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835037
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Aerosol- and Percutaneous-acquired Venezuelan Equine Encephalitis in Humans and Nonhuman Primates for Suitability in Predicting Clinical Efficacy under the Animal Rule.
Rusnak JM; Dupuy LC; Niemuth NA; Glenn AM; Ward LA
Comp Med; 2018 Oct; 68(5):380-395. PubMed ID: 30282570
[TBL] [Abstract][Full Text] [Related]
31. A Quantitative Real-Time RT-PCR Assay for the Detection of
Vina-Rodriguez A; Eiden M; Keller M; Hinrichs W; Groschup MH
Biomed Res Int; 2016; 2016():8543204. PubMed ID: 28042576
[No Abstract] [Full Text] [Related]
32. An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice.
White LJ; Parsons MM; Whitmore AC; Williams BM; de Silva A; Johnston RE
J Virol; 2007 Oct; 81(19):10329-39. PubMed ID: 17652394
[TBL] [Abstract][Full Text] [Related]
33. A chimeric Sindbis-based vaccine protects cynomolgus macaques against a lethal aerosol challenge of eastern equine encephalitis virus.
Roy CJ; Adams AP; Wang E; Leal G; Seymour RL; Sivasubramani SK; Mega W; Frolov I; Didier PJ; Weaver SC
Vaccine; 2013 Mar; 31(11):1464-70. PubMed ID: 23333212
[TBL] [Abstract][Full Text] [Related]
34. Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome.
Tretyakova I; Tibbens A; Jokinen JD; Johnson DM; Lukashevich IS; Pushko P
Vaccine; 2019 May; 37(25):3317-3325. PubMed ID: 31072736
[TBL] [Abstract][Full Text] [Related]
35. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
36. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.
Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I
J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087
[TBL] [Abstract][Full Text] [Related]
37. [The vaccines based on the replicon of the venezuelan equine encephalomyelitis virus against viral hemorrhagic fevers].
Petrov AA; Plekhanova TM; Sidorova ON; Borisevich SV; Makhlay AA
Vopr Virusol; 2015; 60(3):14-8. PubMed ID: 26281301
[TBL] [Abstract][Full Text] [Related]
38. The genetic adjuvant IL-12 enhances the protective efficacy of a DNA vaccine for Venezuelan equine encephalitis virus delivered by intramuscular injection in mice.
Suschak JJ; Bagley K; Six C; Shoemaker CJ; Kwilas S; Spik KW; Dupuy LC; Schmaljohn CS
Antiviral Res; 2018 Nov; 159():113-121. PubMed ID: 30268913
[TBL] [Abstract][Full Text] [Related]
39. Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection.
Calvert AE; Bennett SL; Hunt AR; Fong RH; Doranz BJ; Roehrig JT; Blair CD
Virology; 2022 Jan; 565():13-21. PubMed ID: 34626907
[TBL] [Abstract][Full Text] [Related]
40. Designing multivalent immunogens for alphavirus vaccine optimization.
Read CM; Plante K; Rafael G; Rossi SL; Braun W; Weaver SC; Schein CH
Virology; 2021 Sep; 561():117-124. PubMed ID: 33823988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
